Kalbe Genexine Biologics is based in Jakarta, Indonesia. It has raised $55M in total funding. Backed by General Atlantic.
Kalbe Genexine Biologics funding overview
Kalbe Genexine Biologics is based in Jakarta, Indonesia. Kalbe Genexine Biologics has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for Kalbe Genexine Biologics runs through 2021; nothing later has been disclosed. Investors on record include General Atlantic.
Kalbe Genexine Biologics at a glance
Total raised
$55M
Latest round date
January 2021
Headquarters
Jakarta, Indonesia
Notable investors
General Atlantic
Frequently asked about Kalbe Genexine Biologics funding
How much has Kalbe Genexine Biologics raised?
Kalbe Genexine Biologics has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Kalbe Genexine Biologics?
General Atlantic are named among the investors backing Kalbe Genexine Biologics.
What was the latest Kalbe Genexine Biologics funding round?
No round stage has been disclosed for Kalbe Genexine Biologics.
Where is Kalbe Genexine Biologics based?
Kalbe Genexine Biologics is based in Jakarta, Indonesia.
When did Kalbe Genexine Biologics last raise?
The last disclosed Kalbe Genexine Biologics round closed in January 2021.
We update the Kalbe Genexine Biologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Jakarta and their backers are listed below.
Companies related to Kalbe Genexine Biologics (36)
